Delivery Order SPE2DB22D2211-SPE2DB25FSBCW
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,780.86 Firm Fixed Price Delivery Order is for the supply of Ondansetron ODT 4 mg Tablets in a 30-count package. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,577.14 firm fixed-price delivery order is for the supply of 4560726475 Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of April 27, 2023 and was awarded on April 26, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $46,836.72 from the Defense Logistics Agency (DLA) for the supply of 4,560,650 units of the drug Ondansetron ODT 4 mg tablet. The contract has a period of performance through April 20, 2023, and utilizes a firm fixed price pricing structure. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,058.89 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- The Defense Logistics Agency awarded a delivery order valued at $19,014.45 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award, which carries no set-aside designation, utilizes firm fixed price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of ondansetron ODT 4 mg tablets. The contract is a delivery order with a firm fixed price of $17,942.55 and a period of performance through March 4, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for supplying a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,987.36 Firm Fixed Price delivery order is for the supply of Ondansetron ODT 4 mg Tablets in 30-count packages. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,837.55 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units. This contract, awarded on July 18, 2025, utilizes a firm fixed price structure with an ultimate completion date of July 21, 2025. The award was not designated as a set-aside contract, indicating competitive award status. Performance will be conducted from AmerisourceBergen's Conshohocken, Pennsylvania location, the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,327.73 Firm Fixed Price Delivery Order is for the supply of 4,564,802,515 units of Ondansetron ODT 4 mg Tablets. The contract has an ultimate completion date of June 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $23,989.62 firm-fixed-price delivery order is for the supply of 4,566,100 units of the medication Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBCWDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency for Ondansetron ODT 4 mg tablets (30-count supply) valued at $4,396.53 with a firm fixed price structure. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside competitive award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, with particular focus on military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries through the DLA Medical Supply Chain, encompassing branded and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent SPE2DX contract provides a comprehensive global pharmaceutical support vehicle enabling the company to supply medical products to support military healthcare programs and other government agencies, including the Defense Health Agency and U.S. Coast Guard, worldwide. This delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's established federal contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/18/25 |